Abstract
Purpose
To retrospectively identify the radiological and clinical features of neuroendocrine neoplasms of the extrahepatic bile duct.
Materials and methods
Institutional review board approval was obtained. Between August 2003 and August 2013, 11 patients (range 41–79 years) who had undergone surgery in our institution for neuroendocrine neoplasms of the extrahepatic bile duct were identified. Clinical features (symptoms, laboratory finding, and medical history) were reviewed. A pathologist reviewed the pathology of 11 patients. CT (n = 11), MRI (n = 10), and PET/CT (n = 8) were reviewed by two radiologists in consensus. They were blinded to the clinical features and pathology report. The tumor location was assessed on CT and was classified as occurring in the common hepatic duct, cystic duct, and common bile duct. The tumor shape was assessed in ten patients using MRI and in one patient using CT. The shape was classified as nodular, intraductal-growing, and periductal-infiltrating type. The FDG activity on PET/CT was also evaluated. Correlation of image findings with pathology was made by a radiologist who didn’t participate in the image analysis.
Results
There were five men and six women and their median age was 65 years. On pathology examination, seven patients had neuroendocrine carcinoma (64%), three had mixed adenoneuroendocrine carcinoma (27%), and one had neuroendocrine tumor (9%). CT showed that the tumors were located in the common bile duct in seven patients (64%), the common hepatic duct in two (18%), and the cystic duct in two patients (18%). Five tumors were classified as nodular (45%), five as intraductal-growing (45%), and one as periductal-infiltrating type (9%). PET/CT showed increased FDG activity, ranging from 2.7–15.9, in eight patients with neuroendocrine carcinoma.
Conclusion
The most common location of neuroendocrine neoplasms of the extrahepatic bile duct is the common bile duct. Most of them are nodular or intraductal-growing type.
Similar content being viewed by others
References
Lawrence B, Gustafsson BI, Chan A, et al. (2011) The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 40(1):1–18
Hauso O, Gustafsson BI, Kidd M, et al. (2008) Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113(10):2655–2664
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. In: Komminoth P (ed) Neuroendocrine neoplasms of the gallbladder and extrahepatic bile duct, 4th edn. International Agency for Research on Cancer Press, Lyon, pp: 274–276.
Shia J, Tang LH, Weiser MR, et al. (2008) Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 32(5):719–731
Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR 181(3):819–827
Rindi G, Kloppel G, Couvelard A, et al. (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451(4):757–762
Edge SB (2010) American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, pp 211–233
Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR 168(6):1439–1443
Engels JT, Balfe DM, Lee JK (1989) Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology 172(1):35–40
Kim JE, Lee JM, Kim SH, et al. (2010) Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 257(2):364–372
Maggard MA, O’Connell JB, Ko CY (2004) Updated population-based review of carcinoid tumors. Ann Surg 240(1):117–122
Tsai HJ, Wu CC, Tsai CR, et al. (2013) The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PloS One 8(4):e62487
Cho MY, Kim JM, Sohn JH, et al. (2012) Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000–2009: multicenter study. Cancer Res Treat 44(3):157–165
Barron-Rodriguez LP, Manivel JC, Mendez-Sanchez N, Jessurun J (1991) Carcinoid tumor of the common bile duct: evidence for its origin in metaplastic endocrine cells. Am J Gastroenterol 86(8):1073–1076
Chamberlain RS, Blumgart LH (1999) Carcinoid tumors of the extrahepatic bile duct. A rare cause of malignant biliary obstruction. Cancer 86(10):1959–1965
Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959
Modlin IM, Shapiro MD, Kidd M (2005) An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg 29(1):92–101
Hao L, Friedman AL, Navarro VJ, West B, Robert ME (1996) Carcinoid tumor of the common bile duct producing gastrin and serotonin. J Clin Gastroenterol 23(1):63–65
Felekouras E, Petrou A, Bramis K, et al. (2009) Malignant carcinoid tumor of the cystic duct: a rare cause of bile duct obstruction. Hepatobiliary Pancreat Dis Int 8(6):640–646
Sethi H, Madanur M, Srinivasan P, et al. (2007) Non-functioning well-differentiated neuroendocrine tumor of the extrahepatic bile duct: an unusual suspect? Hepatobiliary Pancreat Dis Int 6(5):549–552
Takahashi K, Sasaki R, Oshiro Y, et al. (2012) Well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst. Int Surg 97(4):315–320
Tonnhofer U, Balassy C, Reck CA, Koller A, Horcher E (2009) Neuroendocrine tumor of the common hepatic duct, mimicking a choledochal cyst in a 6-year-old child. J Pediatr Surg 44(6):E23–E25
Ueyama T, Ding J, Hashimoto H, Tsuneyoshi M, Enjoji M (1992) Carcinoid tumor arising in the wall of a congenital bile duct cyst. Arch Pathol Lab Med 116(3):291–293
Onishi I, Kitagawa H, Harada K, et al. (2013) Intraductal papillary neoplasm of the bile duct accompanying biliary mixed adenoneuroendocrine carcinoma. World J Gastroenterol 19(20):3161–3164
Joo I, Lee JM (2013) Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging 38(6):1334–1350
Nikolaidis P, Hammond NA, Day K, et al. (2014) Imaging features of benign and malignant ampullary and periampullary lesions. Radiographics 34(3):624–641
Elias E, Hamlyn AN, Jain S, et al. (1976) A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology 71(3):439–443
Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M (1977) Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 39(1):232–246
Alexander F, Rossi RL, O’Bryan M, et al. (1984) Biliary carcinoma: A review of 109 cases. Am J Surg 147(4):503–509
Kulke MH, Benson AB 3rd, Bergsland E, et al. (2012) Neuroendocrine tumors. J Natl Compr Cancer Netw 10(6):724–764
Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16(3):978–985
Adams S, Baum R, Rink T, et al. (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25(1):79–83
Masui T, Doi R, Ito T, et al. (2010) Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification. Oncol Lett 1(1):155–159
Kayani I, Bomanji JB, Groves A, et al. (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68 Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112(11):2447–2455
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, N., Kim, H.J., Byun, J.H. et al. Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics. Abdom Imaging 40, 181–191 (2015). https://doi.org/10.1007/s00261-014-0191-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0191-0